Surgical Resection and Pazopanib Treatment for Recurrent Cardiac Angiosarcoma

Cardiac sarcoma treatment is challenging for surgeons because of frequent tumor recurrence and poor prognosis. In addition, optimal management of recurrences is not well established. The multi-targeted tyrosine kinase inhibitor, pazopanib, was recently approved for soft-tissue sarcoma. Herein, we pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Pathol
Autors principals: Nakamura, Yuki, Toda, Koichi, Miyagawa, Shigeru, Yoshikawa, Yasushi, Hata, Hiroki, Domae, Keitaro, Matsuura, Ryohei, Sawa, Yoshiki
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2019
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546942/
https://ncbi.nlm.nih.gov/pubmed/31211293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2632010X19831261
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars